初次全膝关节置换术前一年非手术治疗膝骨关节炎的费用
该观察性队列研究利用IBM Watson Health MarketScan数据库,纳入2018年1月1日至2019年12月31日期间接受单侧孤立初次全膝关节置换的晚期膝骨关节炎患者24492例,平均年龄60.4±8.0岁。结果显示,术前一年非手术治疗人均总费用为1355±2087美元,其中关节内注射透明质酸人均费用最高(1019±913美元),女性患者费用高于男性(1440±2159美元 vs 1254±1992美元,p<0.01),东北地区患者费用最高(1740±2437美元)。
要点
- 初次全膝关节置换术前一年非手术治疗人均总费用为1355±2087美元。
- 关节内注射糖皮质激素是最常见的非手术治疗(54.3%)。
- 女性患者非手术治疗总费用高于男性(1440±2159美元 vs 1254±1992美元,p<0.01)。
核心结论
- 晚期膝骨关节炎患者非手术治疗的类型和费用存在较大差异。
- 未来研究应探究非手术治疗在不同疾病阶段的有效性。
研究设计与样本
- 观察性队列研究,使用IBM Watson Health MarketScan数据库。
- 纳入2018年1月1日至2019年12月31日期间接受单侧孤立初次全膝关节置换的晚期膝骨关节炎患者,共24492例,平均年龄60.4±8.0岁。
- 主要结局为术前一年内已识别的非手术治疗相关的膝骨关节炎费用。
主要发现
- 非手术治疗人均总费用为1355±2087美元。
- 最常见的非手术治疗为关节内注射糖皮质激素(54.3%)。
- 人均费用最高的非手术治疗为关节内注射透明质酸(1019±913美元)。
- 女性患者非手术治疗总费用高于男性(1440±2159美元 vs 1254±1992美元,p<0.01)。
- 东北地区患者费用最高(1740±2437美元)。
关键数值与推荐
- 非手术治疗包括物理治疗、支具、关节内注射(专业费、透明质酸、糖皮质激素)、药物(非甾体抗炎药、阿片类、对乙酰氨基酚)和膝关节特异性影像。
- 14346例(58.6%)患者接受超过1种非手术治疗,7831例(32.0%)患者接受至少3种非手术治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The convergence of national priorities to reduce health-care costs and deliver high-value care warrants the need to examine health-care utilization. The objective of this study was to describe the costs associated with nonoperative procedures in the 1-year period leading up to primary total knee arthroplasty (TKA). METHODS: An observational cohort study was conducted using the IBM Watson Health MarketScan databases. Patients with late-stage knee osteoarthritis (OA) who underwent unilateral, isolated primary TKA from January 1, 2018, to December 31, 2019, were included. The main outcome was the cost of knee OA-related payments for identified nonoperative procedures in the 1-year period before surgery. Nonoperative procedures examined were (1) physical therapy (PT); (2) bracing; (3) intra-articular injections: professional fee, hyaluronic acid (IA-HA), and corticosteroids (IA-CS); (4) medication: nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, and acetaminophen; and (5) knee-specific imaging. RESULTS: The study population included 24,492 TKA patients with a mean age of 60.4 ± 8.0 years. The average total cost of nonoperative procedures per patient was $1,355 ± $2,087. The most common nonoperative treatment prescribed was IA-CS (54.3%). The nonoperative procedure with the highest cost per patient was IA-HA ($1,019 ± $913 per patient). The total cost of nonoperative procedures was higher among female compared with male patients ($1,440 ± $2,159 versus $1,254 ± $1,992 per patient; p < 0.01). The highest costs were found for patients in the Northeast ($1,740 ± $2,437 per patient). A total of 14,346 (58.6%) and 7,831 (32.0%) of the patients had >1 and ≥3 nonoperative treatments, respectively. CONCLUSIONS: There is substantial variation in the type and the cost of nonoperative treatment for patients with late-stage OA. Future studies should investigate the effectiveness of nonoperative treatments at different stages of the disease. LEVEL OF EVIDENCE: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
引用
- Nin DZ, Chen YW, Talmo CT, et al. Costs of Nonoperative Procedures for Knee Osteoarthritis in the Year Prior to Primary Total Knee Arthroplasty. J Bone Joint Surg Am. 2022. PMID: 36126140. doi:10.2106/JBJS.21.01415
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。